<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>TBE Book</provider_name><provider_url>https://tbenews.com/tbe</provider_url><author_name>IT</author_name><author_url>https://tbenews.com/tbe/author/brianong/</author_url><title>TBE News 2023 - TBE Book</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="z5eQKNgOY6"&gt;&lt;a href="https://tbenews.com/tbe/tbe-news-2023/"&gt;TBE News 2023&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://tbenews.com/tbe/tbe-news-2023/embed/#?secret=z5eQKNgOY6" width="600" height="338" title="&#x201C;TBE News 2023&#x201D; &#x2014; TBE Book" data-secret="z5eQKNgOY6" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://tbenews.com/tbe/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://tbenews.com/tbe/wp-content/uploads/2020/05/tbenewsbanner1.jpg</thumbnail_url><thumbnail_width>1180</thumbnail_width><thumbnail_height>250</thumbnail_height><description>December 2023 Newsletter: TBE vaccines can induce antibodies to non-structural protein 1 (NS-1) Snapshot 51/2023 TBE in dogs, Lithuania Snapshot 50/2023 Specific TBE antibody determination by a new ELISA based on recombinant glycoprotein E domains Snapshot 49/2023 Analyzing escape mutants to human monoclonal antibodies with broad TBE virus neutralizing capacity November 2023 Newsletter: Recommendations of the Advisory Committee on Immunization Practices on the TBE vaccine licensed in the United States Snapshot 48/2023 TBE risk assessment, attitudes and practices among tourists to an Italian high-risk area Snapshot 47/2023 Emergency department syndromic surveillance to monitor tick-borne diseases Snapshot 46/2023 Prevalence of TBE antibodies in wild ungulates in northern Italy Snapshot 45/2023 Protection of Langat virus antibodies against lethal TBE virus infection in mice Snapshot 44/2023 TBE in a horse, Austria October 2023 Newsletter: History of TBE and TBE vaccine development Snapshot 43/2023 A new real-time PCR method to distinguish Siberian from European subtypes of TBE virus Snapshot 42/2023 Ixodes persulcatus&#xA0;in Sweden and Finland Snapshot 41/2023 Development of a TBE vaccine to protect dogs Snapshot 40/2023 TBE in Croatia September 2023 Newsletter: Effectiveness of TBE vaccines in children, Latvia Snapshot 39/2023 Analyzing biomarkers of prognostic value for severity of TBE Snapshot 38/2023 Partial protection against lethal infection of mice by recombinant nonstructural protein 1 of TBE virus Snapshot 37/2023 Multiple functions of the non-structural protein 1 of flaviviruses Snapshot 36/2023 TBE in Mongolia August 2023 Newsletter: Effectiveness of TBE vaccination in Latvia Snapshot 35/2023 Seroprevalence study for Lyme disease and TBE in forestry workers in northern France Snapshot 34/2023 Origin of the Baikal subtype of TBE virus Snapshot 33/2023 Testing nucleoside/nucleotide analogs against TBE virus and West Nile virus Snapshot 32/2023 Assessing ribavirin as an anti-TBE virus drug July 2023 Newsletter: A TBE seroprevalence study in animals confirms known TBE foci and suggests so far unknown foci in northern Germany Snapshot 31/2023 A cluster of eight TBE virus infections in Poland by consumption of non-pasteurized goat milk Snapshot 30/2023 Virus-like particle-based vaccine to protect against TBE virus infection Snapshot 29/2023 Assessment in mice of a recombinant TBE vaccine based on Modified Vaccinia virus Ankara Snapshot 28/2023 Characterization of a strain isolated in the Netherlands and which is highly divergent from TBE-EU strains Snapshot 27/2022 Analyzing the increase of TBE incidence in Scandinavia June 2023 Newsletter: Mixed immunization with two TBE vaccine brands increases the neutralization titers against a variety of TBE-EU strains Snapshot 26/2023 Analyzing two TBE vaccine failures: was antibody mismatch the cause? Snapshot 25/2023 Knowledge, attitudes and behaviors among physicians regarding TBE in southern Snapshot 24/2023 Testing accelerated TBE vaccination schedules for last-minute travelers Snapshot 23/2023 Long-lasting TBE antibody persistence after vaccination May 2023 Newsletter: Sequelae of TBE Snapshot 22/2023 Horses as sentinels for flavivirus infection Snapshot 21/2023 Analyses of ticks and humans bitten by ticks for TBE and borreliosis Snapshot 20/2023 Surveillance study in southwestern Germany: Discrimination between vaccine- and infection-induced TBE antibodies Snapshot 19/2023 Fourth case of TBE in the United Kingdom Snapshot 18/2023 Underdiagnosis of TBE in Germany April 2023 Newsletter: Acute clinical manifestations of TBE Snapshot 17/2023 TBE in the EU/EEA, 2012&#x2013;2020 Snapshot 16/2023 TBE seropositivity of sheep in southern Germany Snapshot 15/2023 TBE vaccine field effectiveness against severe and mild forms of disease Snapshot 14/2023 Seroprotection rates vs. vaccination rates in southern Germany March 2023 Newsletter: TBE cases in Central Europe, 2022 Snapshot 13/2023 Concomitant application of flavivirus vaccines Snapshot 12/2023 Cross-reactivity among sera from various flaviviruses Snapshot 11/2023 Immunization status in patients with multiple sclerosis, Austria Snapshot 10/2023 Severe TBE virus infection of a pregnant woman February 2023 Newsletter: TBE in children Snapshot 9/2023 TBE seroprevalence in mice from natural TBE foci Snapshot 8/2023 TBE and TBE vaccination in Hungary Snapshot 7/2023 Spanish goat encephalitis virus: a significant pathogen of goats Snapshot 6/2023 Low TBE vaccination rate among German soldiers January 2023 Newsletter: A new candidate TBE vaccine based on recombinantly produced virus-like particles in protozoan cells Snapshot 5/2023 TBE and other flaviviruses in the Chelyabinsk region, Russia Snapshot 4/2023 Strong increase in new TBE foci in southern Germany Snapshot 3/2023 TBE vaccine coverage in Switzerland Snapshot 2/2023 The search for drugs to treat TBEvirus Snapshot 1/2023 Fatal TBE case in a Serbian tourist 2022 TBE Newsletters and Snapshots &gt;&gt;&gt; read more&lt;&lt;&lt; 2021 TBE Newsletters and Snapshots &gt;&gt;&gt; read more&lt;&lt;&lt; 2020 TBE Newsletters and Snapshots &gt;&gt;&gt; read more&lt;&lt;&lt; 2019 TBE Newsletters and Snapshots &gt;&gt;&gt; read more&lt;&lt;&lt; 2018&nbsp;TBE Newsletters and Snapshots &gt;&gt;&gt; read more&lt;&lt;&lt;</description></oembed>
